Leteprinim potassium
Alternative Names: AIT 082; Neotrofin; SPI-205Latest Information Update: 12 Jan 2024
At a glance
- Originator Spectrum Pharmaceuticals
- Class Aminobenzoic acids; Hypoxanthines; Neuroprotectants; Small molecules
- Mechanism of Action Nerve growth factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Peripheral nervous system diseases
- Discontinued Alzheimer's disease; Parkinson's disease; Spinal cord injuries
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for phase-I development in Peripheral-nervous-system-diseases in USA (SC, Injection)
- 21 Apr 2011 Preclinical development is ongoing
- 23 Jun 2008 Preclinical development is ongoing